The inspection was conducted at Granules Pharmaceuticals Inc. (GPI) from July 31, 2023 to August 03, 2023
Proposed acquisition represents meaningful step forward in Biogen’s strategy for sustainable growth
Dignitaries and delegates commend India’s leadership in Global South during G20 India Presidency
Convergent action on AMR identified as an important area of intervention
New facility will strengthen the security of supply for global pharmaceutical and biotech customers and will support the continued development and production of lifesaving clinical and commercial-scale therapeutics for patients worldwide.
For the treatment of Superficial Femoral Artery
The increase in revenue and profits for the year was driven by business growth in the US market and growth in our subsidiaries in Canada & Brazil.
Operating EBITDA increased by 21% to INR 181 crores in Q4 FY23
Glucon-D, Sugar Free, EverYuth Scrub, Peel Off Face Mask and Nycil maintained their leadership positions in their respective categories as on March 2023
Krsnaa Diagnostics has commenced its fourth out of eight Diagnostics Center in Ayodhya
Subscribe To Our Newsletter & Stay Updated
